108 related articles for article (PubMed ID: 7298290)
1. Triple drug chemotherapy in treatment of prostate adenocarcinoma Nb Pr A.I.-III.
Drago JR; Worgul TJ
Invest Urol; 1981 Nov; 19(3):191-3. PubMed ID: 7298290
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapeutic treatment of the Nb rat adenocarcinoma androgen-insensitive tumor III.
Drago JR
J Surg Oncol; 1982 Dec; 21(4):264-6. PubMed ID: 7144207
[TBL] [Abstract][Full Text] [Related]
3. The use of the Nb rat in combination chemotherapeutic experiments for prostate cancer.
Drago JR; Smith J
In Vivo; 1991; 5(1):41-2. PubMed ID: 1932624
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of chemotherapeutic responsiveness in Nb rat prostate cancer model. 5-fluorouracil, methotrexate, cyclophosphamide, and adriamycin.
Drago JR; Goldman L; Gershwin ME
Invest Urol; 1980 Jul; 18(1):80-1. PubMed ID: 7410017
[TBL] [Abstract][Full Text] [Related]
5. The evaluation of heparin in control of metastasis of Nb rat androgen-insensitive prostate carcinoma.
Drago JR; Weed P; Fralisch A
Anticancer Res; 1984; 4(3):171-2. PubMed ID: 6540544
[TBL] [Abstract][Full Text] [Related]
6. Treatment of an Nb-Pr-A.I.-3 (autonomous) tumor with combination chemotherapy.
Drago JR; Worgul T
Cancer Chemother Pharmacol; 1981; 5(3):163-6. PubMed ID: 7197592
[TBL] [Abstract][Full Text] [Related]
7. Therapeutic manipulation of Nb rat prostatic adenocarcinomas: chemotherapeutic evaluation of autonomous tumors.
Drago JR; Goldman LB; Maurer RE; Gershwin ME; Eckels DD
Invest Urol; 1979 Nov; 17(3):203-6. PubMed ID: 500317
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of nonhormonal cytotoxic chemotherapy in the Nb rat prostate adenocarcinoma: autonomous tumor (18-Pr and 13-Pr).
Drago JR; Goldman LB; Gershwin ME
Cancer; 1980 Jul; 46(2):273-8. PubMed ID: 7388771
[TBL] [Abstract][Full Text] [Related]
9. Combination chemotherapy in a prostate tumor model: Nb rat prostatic adenocarcinoma model.
Drago JR; Worgul T; Gershwin ME
J Surg Oncol; 1981; 16(4):353-63. PubMed ID: 7195962
[TBL] [Abstract][Full Text] [Related]
10. Further experience with chemotherapy in the Dunning prostatic adenocarcinoma.
Block NL; Camuzzi F; Stover B; Claflin A; Troner M; Politano VA
Trans Am Assoc Genitourin Surg; 1978; 70():57-9. PubMed ID: 753023
[TBL] [Abstract][Full Text] [Related]
11. Doxorubicin, mitomycin, and 5-FU (DMF) in the treatment of hormone-resistant stage D prostate cancer: a preliminary report.
Logothetis CJ; von Eschenbach AC; Samuels ML; Trindade A; Johnson DE
Cancer Treat Rep; 1982 Jan; 66(1):57-63. PubMed ID: 7053267
[TBL] [Abstract][Full Text] [Related]
12. Nb rat prostate adenocarcinoma model: metastasis.
Drago JR; Curley RM; Sipio JC
Anticancer Res; 1985; 5(2):193-6. PubMed ID: 2581494
[TBL] [Abstract][Full Text] [Related]
13. Combination chemotherapy for bronchogenic carcinoma with doxorubicin, BCNU, and cyclophosphamide (ABC): a pilot study of the Southeastern Cancer Study Group.
Denes AE; Presant CA; Bartolucci A
Cancer Treat Rep; 1982 Jan; 66(1):199-200. PubMed ID: 7053258
[No Abstract] [Full Text] [Related]
14. Combination chemotherapy of advanced endometrial adenocarcinoma with adriamycin, cyclophosphamide, 5-fluorouracil, and medroxyprogesterone acetate.
Bruckner HW; Deppe G
Obstet Gynecol; 1977 Jul; 50(1 Suppl):10s-12s. PubMed ID: 876531
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of PC-3 human androgen-independent prostate cancer and its metastases by cytotoxic somatostatin analogue AN-238.
Plonowski A; Schally AV; Nagy A; Sun B; Szepeshazi K
Cancer Res; 1999 Apr; 59(8):1947-53. PubMed ID: 10213505
[TBL] [Abstract][Full Text] [Related]
16. The Nb rat prostatic adenocarcinoma's dose response to methotrexate and adriamycin.
Drago JR; Palmer J
J Surg Oncol; 1983 Nov; 24(3):215-7. PubMed ID: 6632910
[TBL] [Abstract][Full Text] [Related]
17. Radiotherapy and concomitant chemoradiotherapy in the NB rat prostate adenocarcinoma model.
Klump R; Pieters RS; Smith JJ; Badalament RA; Drago JR
In Vivo; 1989; 3(2):109-11. PubMed ID: 2519835
[TBL] [Abstract][Full Text] [Related]
18. Lack of clinical therapeutic synergism between cyclophosphamide, adriamycin, and cis-dichlorodiammineplatinum(II) in metastatic human colorectal carcinoma.
O'Connell MJ; Moertel CG; Rubin J; Schutt AJ; Creagan ET
Cancer Treat Rep; 1980; 64(2-3):311-3. PubMed ID: 7190870
[TBL] [Abstract][Full Text] [Related]
19. Adriamycin (NSC-123127) versus 5-fluorouracil (NSC-19893) and cyclophosphamide (NSC-26271) in the treatment of metastatic prostate cancer.
Eagan RT; Hahn RG; Myers RP
Cancer Treat Rep; 1976 Jan; 60(1):115-7. PubMed ID: 1000515
[No Abstract] [Full Text] [Related]
20. The Nb rat prostatic adenocarcinoma model system.
Drago JR; Goldman LB; Maurer RE
Prog Clin Biol Res; 1980; 37():265-91. PubMed ID: 7384086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
